A safe contraceptive method for women of reproductive age with obesity

Г.У. Султанмуратова, Г.С. Бабаджанова, Ж.Б. Назарбаев, Н.М. Керимова

Shoshilinch tibbiyot axborotnomasi · 2023-yil

Annotatsiya

Aim. The purpose of this study is to determine the safety of using a drospirenone-containing combinedoral contraceptive (СOC) in overweight/obese women of reproductive age.Material and methods. The study included 65 women of reproductive age who were prescribed OC with30 µg of ethinyl estradiol and 3 mg of drospirenone for 3 months for therapeutic and preventive purposes.The main parameters evaluated were lipid and carbohydrate metabolism.Results. According to the results of the study, a favorable effect of low-dose COCs on body weight and lipidprofile was revealed without significant changes in carbohydrate metabolism.Conclusion. СOC may be recommended for overweight/obese patients to control fertility in the postpartum period.

Maqola ma’lumotlari
MualliflarГ.У. Султанмуратова, Г.С. Бабаджанова, Ж.Б. Назарбаев, Н.М. Керимова
JurnalShoshilinch tibbiyot axborotnomasi
Nashr sanasi2023-01-01
Jild15
Son5
Tilen
DOI10.54185/tbem/vol15_iss5/a6

Shoshilinch tibbiyot axborotnomasi jurnalidan boshqa maqolalar

Shoshilinch tibbiyot axborotnomasi — barcha maqolalar